{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:41:44Z","timestamp":1769175704167,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV ID - 024130"],"award-info":[{"award-number":["INV ID - 024130"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011858","name":"African Academy of Sciences","doi-asserted-by":"publisher","award":["SARS-CoV2-4-004"],"award-info":[{"award-number":["SARS-CoV2-4-004"]}],"id":[{"id":"10.13039\/501100011858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"WHO AFRO","award":["2021\/1166179-0"],"award-info":[{"award-number":["2021\/1166179-0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic has exposed vulnerabilities in infectious disease surveillance, especially in West Africa where endemic viruses including Lassa fever persist. The overlapping clinical symptoms of these two infections create diagnostic challenges and the possibility of undetected co-infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study was conducted using archived serum samples from a nationwide SARS-CoV-2 seroprevalence survey in Ghana. 434 samples across six regions were tested for SARS-CoV-2 total antibodies (IgG\/IgM) using the WANTAI ELISA kit and Lassa virus IgG using ReLASV Pan-Lassa-NP-IgG ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SARS-CoV-2 antibody prevalence was 64.29% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009279) and Lassa virus IgG prevalence was 20.28% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200988). Of the cohort of subjects who were seropositive for SARS-CoV-2, 20.79% were also seropositive for LASV IgG. Multivariate analysis revealed household size as a strong risk factor of dual exposure. Individuals from medium-sized households (4\u20136 persons) (aOR\u2009=\u20098.78, 95% CI: 1.18\u201365.56,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034) and large households (\u2265\u20097 persons) (aOR\u2009=\u200912.90, 95% CI: 1.99\u201383.40,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) had significantly increased odds of dual seropositivity compared to small households. Regional variations were observed, with Greater Accra showing significantly lower odds of dual seropositivity (aOR\u2009=\u20090.13, 95% CI: 0.03\u20130.51,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004) compared to Ashanti Region.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides serological evidence of SARS-CoV-2 and Lassa virus concurrent exposure in Ghana during the COVID-19 pandemic. This finding suggests large household size as a key driver of dual viral exposure and calls for integrated surveillance systems and targeted interventions in large household settings to reduce concurrent transmission of viruses with pandemic potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12385-1","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:45:28Z","timestamp":1766227528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serological evidence of concurrent Lassa virus and SARS-CoV-2 exposure in Ghana- a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Elizabeth","family":"Obeng-Aboagye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Daakyire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Portia Owusua","family":"Aniapam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Lamptey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Opoku","family":"Gyamfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Frimpong","family":"Gyekye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dorcoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvis Suatey","family":"Lomotey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Owusu","family":"Donkor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"8","key":"12385_CR1","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/jpm12081295","volume":"12","author":"R Filip","year":"2022","unstructured":"Filip R, Gheorghita Puscaselu R, Anchidin-Norocel L, Dimian M, Savage WK. Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems. J Personalized Med. 2022;12(8):1295.","journal-title":"J Personalized Med"},{"issue":"7889","key":"12385_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-021-04188-6","volume":"600","author":"J Li","year":"2021","unstructured":"Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600(7889):408\u201318.","journal-title":"Nature"},{"key":"12385_CR3","unstructured":"WHO. WHO South-East Asia Region. Epidemiological Bulletin 10th Edition. 2025. [Available from: https:\/\/www.who.int\/southeastasia\/outbreaks-and-emergencies\/health-emergency-information-risk-assessment\/sear-epi-bulletins#:~:text=This%20Epidemiological%20bulletin%2C%20published%20by%20%27Health%20Emergency%20Information,to%20inform%20risk%20assessment%20and%20response%20by%20countries]."},{"issue":"12","key":"12385_CR4","doi-asserted-by":"publisher","first-page":"e0279467","DOI":"10.1371\/journal.pone.0279467","volume":"17","author":"MM Dalhat","year":"2022","unstructured":"Dalhat MM, Olayinka A, Meremikwu MM, Dan-Nwafor C, Iniobong A, Ntoimo LF, et al. Epidemiological trends of Lassa fever in Nigeria, 2018\u20132021. PLoS ONE. 2022;17(12):e0279467.","journal-title":"PLoS ONE"},{"issue":"4","key":"12385_CR5","first-page":"933","volume":"33","author":"DA Asogun","year":"2019","unstructured":"Asogun DA, G\u00fcnther S, Akpede GO, Ihekweazu C, Zumla A. Lassa fever: epidemiology, clinical features, diagnosis, management and prevention. Infect Disease Clin. 2019;33(4):933\u201351.","journal-title":"Infect Disease Clin"},{"key":"12385_CR6","unstructured":"Lassa Fever NCDC. Situation Report. 2025. [Available from: https:\/\/ncdc.gov.ng\/themes\/common\/files\/sitreps\/fef1494f70b0a5330dc39f362b6c5dd6.pdf]."},{"key":"12385_CR7","doi-asserted-by":"publisher","first-page":"1542842","DOI":"10.3389\/fpubh.2025.1542842","volume":"13","author":"KA Akowuah","year":"2025","unstructured":"Akowuah KA, Ofori MS, Pratt D, Abankwa A, Bonney EY, Enimil N, et al. The epidemiology of Lassa fever in ghana: a study on the 2023 Lassa fever outbreak in Ghana. Front Public Health. 2025;13:1542842.","journal-title":"Front Public Health"},{"issue":"12","key":"12385_CR8","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1002\/jmv.27219","volume":"93","author":"O Uwishema","year":"2021","unstructured":"Uwishema O, Alshareif BA, Yousif MY, Omer ME, Sablay AL, Tariq R, et al. Lassa fever amidst the COVID-19 pandemic in africa: A rising concern, efforts, challenges, and future recommendations. J Med Virol. 2021;93(12):6433\u20136.","journal-title":"J Med Virol"},{"key":"12385_CR9","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.glmedi.2023.100005","volume":"1","author":"CO Aleke","year":"2023","unstructured":"Aleke CO, Mong EU, Obande-Ogbuinya EN, Omaka-Amari LN, Ngwakwe PC, Nashwan AJ. Re-emergence of Lassa fever outbreaks in Africa with ongoing threat from COVID-19. J Med Surg Public Health. 2023;1:100005.","journal-title":"J Med Surg Public Health"},{"issue":"12","key":"12385_CR10","doi-asserted-by":"publisher","first-page":"e2031756","DOI":"10.1001\/jamanetworkopen.2020.31756","volume":"3","author":"ZJ Madewell","year":"2020","unstructured":"Madewell ZJ, Yang Y, Longini IM, Halloran ME, Dean NE. Household transmission of SARS-CoV-2: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(12):e2031756\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"12385_CR11","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2542-5196(22)00149-8","volume":"6","author":"MG Chipeta","year":"2022","unstructured":"Chipeta MG, Kumaran EP, Browne AJ, Hamadani BHK, Haines-Woodhouse G, Sartorius B, et al. Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study. Lancet Planet Health. 2022;6(8):e670\u201381.","journal-title":"Lancet Planet Health"},{"issue":"8","key":"12385_CR12","first-page":"1","volume":"2","author":"C Abejegah","year":"2021","unstructured":"Abejegah C, Owhin SO, Abiodun AT, Adeniyi BO. Lassa fever coinfection with COVID-19 among health care workers: report of two cases. Annals Med Res Pract. 2021;2(8):1.","journal-title":"Annals Med Res Pract"},{"issue":"1","key":"12385_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s41182-021-00390-4","volume":"49","author":"ND Nnaji","year":"2021","unstructured":"Nnaji ND, Onyeaka H, Reuben RC, Uwishema O, Olovo CV, Anyogu A. The deuce-ace of Lassa Fever, Ebola virus disease and COVID-19 simultaneous infections and epidemics in West africa: clinical and public health implications. Trop Med Health. 2021;49(1):102.","journal-title":"Trop Med Health"},{"key":"12385_CR14","doi-asserted-by":"publisher","first-page":"1438334","DOI":"10.3389\/fpubh.2024.1438334","volume":"12","author":"A Ashenafi","year":"2024","unstructured":"Ashenafi A, Sule O, Peter T, Mashate S, Otieno O, Kebede A, et al. Diagnostics for detection and surveillance of priority epidemic-prone diseases in africa: an assessment of testing capacity and laboratory strengthening needs. Front Public Health. 2024;12:1438334.","journal-title":"Front Public Health"},{"key":"12385_CR15","doi-asserted-by":"crossref","unstructured":"Keita M, Cherif MS, Sivahera B, Boland ST, Banza-Mutoka F, Kourouma M, et al. COVID-19 and lassa fever coinfection in an Ebola suspected patient in Guinea. 2022.","DOI":"10.4269\/ajtmh.21-0713"},{"key":"12385_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2022.01.058","volume":"117","author":"SS Musa","year":"2022","unstructured":"Musa SS, Zhao S, Abdullahi ZU, Habib AG, He D. COVID-19 and Lassa fever in nigeria: A deadly alliance? Int J Infect Dis. 2022;117:45\u20137.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"12385_CR17","doi-asserted-by":"publisher","first-page":"e0001851","DOI":"10.1371\/journal.pgph.0001851","volume":"3","author":"I Owusu Donkor","year":"2023","unstructured":"Owusu Donkor I, Mensah SK, Dwomoh D, Akorli J, Abuaku B, Ashong Y, et al. Modeling SARS-CoV-2 antibody Seroprevalence and its determinants in ghana: A nationally representative cross-sectional survey. PLOS Global Public Health. 2023;3(5):e0001851.","journal-title":"PLOS Global Public Health"},{"key":"12385_CR18","unstructured":"G.S.S. Ghana 2021 Population and Housing Census General Report Volume 3A: Population and Population of Regions and Districts. 2021. [Available from: https:\/\/statsghana.gov.gh\/gssmain\/fileUpload\/pressrelease\/2021%20PHC%20General%20Report%20Vol%203A_Population%20of%20Regions%20and%20Districts_181121.pdf]."},{"issue":"7426","key":"12385_CR19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327(7426):1271\u20135.","journal-title":"BMJ"},{"key":"12385_CR20","unstructured":"WHO. Lassa fever 2024. [Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever]."},{"key":"12385_CR21","doi-asserted-by":"crossref","unstructured":"Lokossou VK, Bunyoga D, Sombie I, Okolo S. Coexistence and management of COVID-19 pandemic with other epidemics in West Africa: lessons learnt and policy implications. Pan Afr Med J. 2021;38(1).","DOI":"10.11604\/pamj.2021.38.341.27901"},{"issue":"18","key":"12385_CR22","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1056\/NEJMoa1804498","volume":"379","author":"KJ Siddle","year":"2018","unstructured":"Siddle KJ, Eromon P, Barnes KG, Mehta S, Oguzie JU, Odia I, et al. Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018. N Engl J Med. 2018;379(18):1745\u201353.","journal-title":"N Engl J Med"},{"issue":"1","key":"12385_CR23","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1080\/22221751.2020.1796528","volume":"9","author":"A Yadouleton","year":"2020","unstructured":"Yadouleton A, Picard C, Rieger T, Loko F, Cadar D, Kouthon EC, et al. Lassa fever in benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus. Emerg Microbes Infections. 2020;9(1):1761\u201370.","journal-title":"Emerg Microbes Infections"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12385-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:59:22Z","timestamp":1769173162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12385"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12385-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Procedures in this study conform with the Ghana Public Health Act, 2012 (Act 851) and the Data Protection Act, 2012, and adhered to the principles outlined in the Declaration of Helsinki for research involving human participants. Ethical approval (NMIMR-IRB CPN 075\/19\u201320) was obtained from the Institutional Review Board (IRB) of NMIMR, University of Ghana. Informed consent was obtained from all subjects and\/or their legal guardians (for subjects aged below 18 years). All consenting participants agreed to future use of their samples. Both verbal and written consent was obtained from all participants in the presence of a witness and from the parent\/guardian of minors; this was done to ensure that the study was thoroughly explained to the participants and their parents\/guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}